X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6468) 6468
Book Review (802) 802
Publication (305) 305
Book / eBook (32) 32
Book Chapter (27) 27
Newsletter (16) 16
Newspaper Article (12) 12
Magazine Article (4) 4
Conference Proceeding (3) 3
Government Document (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5900) 5900
index medicus (5708) 5708
female (3943) 3943
male (3566) 3566
gallbladder neoplasms - pathology (3524) 3524
middle aged (3237) 3237
aged (2971) 2971
adult (2052) 2052
gallbladder (1689) 1689
surgery (1648) 1648
cancer (1594) 1594
gallbladder neoplasms - surgery (1568) 1568
gallbladder cancer (1346) 1346
oncology (1282) 1282
carcinoma (1174) 1174
aged, 80 and over (1155) 1155
prognosis (1091) 1091
cholecystectomy (955) 955
gastroenterology & hepatology (943) 943
gallbladder neoplasms - diagnosis (903) 903
adenocarcinoma - pathology (882) 882
neoplasm staging (878) 878
pathology (863) 863
gallbladder - pathology (841) 841
retrospective studies (761) 761
abridged index medicus (694) 694
medicine & public health (656) 656
immunohistochemistry (652) 652
gallbladder neoplasms - mortality (631) 631
diagnosis, differential (621) 621
gallbladder carcinoma (608) 608
tumors (582) 582
treatment outcome (550) 550
diagnosis (541) 541
metastasis (526) 526
bile duct neoplasms - pathology (522) 522
gallbladder neoplasms - diagnostic imaging (495) 495
survival rate (491) 491
tomography, x-ray computed (478) 478
neoplasm invasiveness (455) 455
gallbladder neoplasms - metabolism (443) 443
lymphatic metastasis (431) 431
risk factors (426) 426
animals (424) 424
ultrasonography (417) 417
gastroenterology (411) 411
survival (409) 409
carcinoma - pathology (408) 408
gallbladder neoplasms - genetics (407) 407
adenocarcinoma (402) 402
chemotherapy (395) 395
gallbladder neoplasms - complications (390) 390
analysis (370) 370
adenocarcinoma - surgery (368) 368
expression (356) 356
liver (350) 350
cholangiocarcinoma (340) 340
follow-up studies (340) 340
gallbladder diseases (333) 333
research (332) 332
gallbladder neoplasms - drug therapy (301) 301
liver neoplasms - secondary (292) 292
survival analysis (289) 289
gallbladder neoplasms - epidemiology (283) 283
care and treatment (282) 282
gallbladder neoplasms (280) 280
liver neoplasms - pathology (279) 279
resection (278) 278
cell line, tumor (274) 274
radiology, nuclear medicine & medical imaging (270) 270
laparoscopic cholecystectomy (261) 261
health aspects (257) 257
management (248) 248
bile duct neoplasms - surgery (244) 244
neoplasm metastasis (244) 244
time factors (243) 243
medical prognosis (237) 237
bile (235) 235
biliary tract neoplasms - pathology (233) 233
cholangiocarcinoma - pathology (232) 232
cholecystitis (231) 231
surgical oncology (226) 226
biopsy (225) 225
abdominal surgery (224) 224
adenocarcinoma - secondary (222) 222
gallbladder neoplasms - therapy (222) 222
gallstones (218) 218
mice (214) 214
patients (214) 214
cholecystitis - pathology (209) 209
pancreatic neoplasms - pathology (209) 209
hepatectomy (208) 208
adenocarcinoma - diagnosis (206) 206
laparoscopy (205) 205
adolescent (204) 204
gallbladder neoplasms - secondary (203) 203
hepatology (200) 200
disease (199) 199
kaplan-meier estimate (195) 195
liver neoplasms - surgery (195) 195
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5544) 5544
Japanese (299) 299
German (161) 161
Spanish (137) 137
French (110) 110
Italian (94) 94
Chinese (64) 64
Russian (51) 51
Polish (20) 20
Korean (15) 15
Hungarian (14) 14
Portuguese (8) 8
Danish (7) 7
Dutch (7) 7
Czech (6) 6
Serbian (5) 5
Croatian (4) 4
Romanian (4) 4
Slovak (4) 4
Swedish (4) 4
Turkish (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Surgical Pathology, ISSN 0147-5185, 09/2012, Volume 36, Issue 9, pp. 1279 - 1301
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 9, pp. 2839 - 2852
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 574 - 581
The combination of gemcitabine and oxaliplatin with panitumumab versus gemcitabine and oxaliplatin alone has been evaluated in a phase 2, randomized trial as a... 
KRAS | panitumumab | biliary cancer | chemotherapy | cholangiocarcinoma | gemcitabine and oxaliplatin (GEMOX) | GROWTH-FACTOR-RECEPTOR | GALLBLADDER CANCER | OPEN-LABEL | II TRIAL | CAPECITABINE | ADVANCED CHOLANGIOCARCINOMA | CETUXIMAB | THERAPY | ONCOLOGY | Adenocarcinoma - pathology | Prognosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Adult | Female | Adenocarcinoma - genetics | Bile Duct Neoplasms - genetics | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Ducts, Intrahepatic - pathology | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Treatment Outcome | Adenocarcinoma - drug therapy | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Bile Ducts, Extrahepatic - pathology | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Clinical trials | Usage | Dosage and administration | Gemcitabine | Index Medicus | Abridged Index Medicus
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2015, Volume 83, Issue 6, pp. 1228 - 1235
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 181 - 188
Summary Background Combination chemotherapy with gemcitabine and a platinum-based agent is regarded as a standard treatment for patients with advanced... 
Hematology, Oncology and Palliative Medicine | PLUS GEMCITABINE | CHOLANGIOCARCINOMA | CISPLATIN | ONCOLOGY | ADENOCARCINOMA | PANCREATIC-CANCER | CLINICAL-TRIALS | II TRIAL | COMBINATION | CHEMOTHERAPY | GALL-BLADDER CANCER | Erlotinib Hydrochloride | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Deoxycytidine - adverse effects | Female | Quinazolines - administration & dosage | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Gallbladder Neoplasms - epidemiology | Cholangiocarcinoma - epidemiology | Deoxycytidine - administration & dosage | Biliary Tract Neoplasms - epidemiology | Disease Progression | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Aged | Gallbladder Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Medical colleges | Chemotherapy | Erlotinib | Gemcitabine | Pancreatic cancer | Oncology, Experimental | Clinical trials | Research | Drug therapy, Combination | Cancer | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 10/2002, Volume 95, Issue 8, pp. 1685 - 1695
BACKGROUND. To the authors' knowledge, the significance of postoperative adjuvant chemotherapy in pancreaticobiliary carcinoma has not yet been clarified. A... 
Adjuvant chemotherapy | Pancreatic carcinoma | Bile duct carcinoma | Disease-free survival | Carcinoma of the ampulla of Vater | Survival | Gallbladder carcinoma | BILIARY CARCINOMA | adjuvant chemotherapy | bile duct carcinoma | MITOMYCIN-C | ADENOCARCINOMA | survival | PANCREAS | P53 PROTEIN IMMUNOREACTIVITY | RADIATION-THERAPY | carcinoma of the ampulla of Vater | 5-FLUOROURACIL | EXTRAHEPATIC BILE-DUCT | CANCER-PATIENTS | pancreatic carcinoma | disease-free survival | ONCOLOGY | gallbladder carcinoma | EXPRESSION | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Pancreatic Neoplasms - drug therapy | Fluorouracil - administration & dosage | Common Bile Duct Neoplasms - drug therapy | Adult | Female | Common Bile Duct Neoplasms - surgery | Chemotherapy, Adjuvant | Mitomycins - administration & dosage | Bile Duct Neoplasms - drug therapy | Bile Duct Neoplasms - surgery | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Neoplasm Recurrence, Local | Disease-Free Survival | Gallbladder Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Infusions, Intravenous | Common Bile Duct Neoplasms - pathology | Gallbladder Neoplasms - surgery | Evaluation | Drug therapy | Postoperative care | Gallbladder cancer | Index Medicus | Abridged Index Medicus
Journal Article
Modern Pathology, ISSN 0893-3952, 01/2006, Volume 19, Issue 1, pp. 97 - 105
Estrogen (ER) and progesterone receptor (PR) expression in primary ovarian mucinous tumors and the utility of these markers for distinguishing metastatic... 
Mucinous carcinoma | Estrogen receptor | Mucinous tumor | Ovary | Progesterone receptor | Metastases | mucinous carcinoma | estrogen receptor | MINIMAL DEVIATION ADENOCARCINOMA | GASTROINTESTINAL-TRACT | INTESTINAL-TYPE | mucinous tumor | PATHOLOGY | progesterone receptor | BORDERLINE TUMORS | EPITHELIAL NEOPLASMS | metastases | ovary | CELL ADENOCARCINOMA | ENDOMETRIAL ADENOCARCINOMAS | ENDOCERVICAL ADENOCARCINOMAS | DIAGNOSTIC-CRITERIA | CLINICOPATHOLOGICAL ANALYSIS | Immunohistochemistry | Pancreatic Neoplasms - metabolism | Ovary - chemistry | Humans | Ovarian Neoplasms - pathology | Stomach Neoplasms - metabolism | Stomach Neoplasms - pathology | Uterine Cervical Neoplasms - pathology | Receptors, Estrogen - analysis | Receptors, Progesterone - analysis | Ovarian Neoplasms - secondary | Uterine Cervical Neoplasms - metabolism | Gallbladder Neoplasms - metabolism | Female | Ovarian Neoplasms - metabolism | Colorectal Neoplasms - metabolism | Diagnosis, Differential | Ovary - pathology | Pancreatic Neoplasms - pathology | Adenocarcinoma, Mucinous - secondary | Appendiceal Neoplasms - metabolism | Adenocarcinoma, Mucinous - metabolism | Appendiceal Neoplasms - pathology | Gallbladder Neoplasms - pathology | Colorectal Neoplasms - pathology | Neoplasms, Unknown Primary - metabolism | Neoplasms, Unknown Primary - pathology | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, pp. e85346 - e85346
Metallothionein (MT) has been extensively investigated as a molecular marker of various types of cancer. In spite of the fact that numerous reviews have been... 
KI-67 ANTIGEN-EXPRESSION | HEPATOCELLULAR-CARCINOMA | MOLECULAR MARKERS | TUMOR PROGRESSION | CLINICOPATHOLOGICAL SIGNIFICANCE | MULTIDISCIPLINARY SCIENCES | BREAST CARCINOMAS | SQUAMOUS-CELL CARCINOMA | PROGNOSTIC-SIGNIFICANCE | DRUG-RESISTANCE | CONFERS RESISTANCE | Immunohistochemistry | Metallothionein - metabolism | Prognosis | Ovarian Neoplasms - diagnosis | Humans | Ovarian Neoplasms - pathology | Case-Control Studies | Head and Neck Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasm Metastasis | Liver Neoplasms - diagnosis | Neoplasm Grading | Liver Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Female | Head and Neck Neoplasms - diagnosis | Liver Neoplasms - pathology | Databases, Bibliographic | Ovarian Neoplasms - metabolism | Odds Ratio | Liver cancer | Prostate cancer | Analysis | Metallothionein | Thoracic surgery | Liver | Lung cancer | Bladder | Staining | Biochemistry | Tissues | Ovarian cancer | Metastases | Confidence intervals | Heterogeneity | Ratios | Histopathology | Urinary bladder | Uterus | Rodents | Quality | Head and neck | Gallbladder | Physiology | Bioindicators | Neck | Thyroid | Stomach | Head | Kidneys | Melanoma | Histology | Esophagus | Meta-analysis | Studies | Pathology | Survival analysis | Medical prognosis | Biomarkers | Prostate | Tumors | Kidney transplantation | Cancer | Index Medicus
Journal Article
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 513, Issue 7516, pp. 110 - 114
Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver... 
PROGENITORS | INTRAHEPATIC CHOLANGIOCARCINOMA | HOMEOSTASIS | LIVER-REGENERATION | MULTIDISCIPLINARY SCIENCES | MUTATION | GROWTH | MICE | PROLIFERATION | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Hepatocyte Nuclear Factor 4 - antagonists & inhibitors | Humans | ras Proteins - metabolism | Hepatocytes - pathology | Male | Hepatocytes - metabolism | Bile Duct Neoplasms - enzymology | Cell Differentiation - genetics | Neoplasm Metastasis | Hepatocyte Nuclear Factor 4 - biosynthesis | Female | Bile Duct Neoplasms - genetics | Cell Lineage - genetics | Cholangiocarcinoma - enzymology | Disease Models, Animal | Cell Division - genetics | Proto-Oncogene Proteins - metabolism | Hepatocyte Nuclear Factor 4 - metabolism | Bile Ducts, Intrahepatic - pathology | Mutant Proteins - genetics | Isocitrate Dehydrogenase - genetics | Mice, Transgenic | Mutant Proteins - metabolism | Proto-Oncogene Proteins - genetics | Hepatocyte Nuclear Factor 4 - genetics | Mutation - genetics | Bile Ducts, Intrahepatic - enzymology | Cholangiocarcinoma - pathology | Animals | Cholangiocarcinoma - genetics | Stem Cells - pathology | Isocitrate Dehydrogenase - metabolism | Glutarates - metabolism | Mice | Bile Duct Neoplasms - pathology | Hepatocytes - enzymology | Index Medicus | Càncer | Diferenciació cel·lular | Gallbladder diseases | Metabolisme | Cell diferentiation | Metabolism | Malalties de la vesícula biliar | Cancer
Journal Article